Schizophrenia Research
Volume 116, Issue 1 , Pages 27-34, January 2010

The quality of life among first-episode psychotic patients in the opus trial

Bispebjerg Hospital, Psychiatric Department, Denmark

Received 15 January 2009; received in revised form 8 October 2009; accepted 10 October 2009. published online 09 November 2009.

Abstract 

Background

From an ‘objective’ perspective, treatment of first-episode psychosis has improved in many ways with the development of specialised early and intensive team-based treatment like e.g. the ‘OPUS’ treatment. However, the patients' perspective is also important and was investigated in the ‘OPUS’ study by analysing data concerning quality of life.

Aim

We aimed to investigate the ‘quality of life from patients' perspective’ among a cohort of young adults with a first-episode psychosis at the time of treatment initiation and after two years. Especially, we were interested in analysing if there were any significant effects on the subjective quality of life of receiving an intensive psychosocial assertive community treatment called ‘OPUS’ compared to standard treatment (ST).

Method

This study is part of the Danish ‘OPUS’ trial, a randomised controlled trial (RCT) comparing ‘treatment as usual’ (standard treatment, ST) with ‘OPUS’ treatment. The Lancashire Quality of Life Profile (LQoLP), which is a combined objective and subjective instrument, was administered at baseline and after two years of treatment, N=280.

Results

The intensive ‘OPUS’ treatment did not affect the quality of life measured by Lancashire QoLP in a significantly different way from the standard treatment (ST). There were no significant differences in quality of life between the ST group and the OPUS group concerning the 9 life domains. Quality of life correlated with psychopathology (both psychotic and negative symptoms) to a minor extent and more strongly with the affective balance and level of self-esteem.

Keywords: First-episode psychosis, Quality of life, Social factors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(09)00493-9

doi:10.1016/j.schres.2009.10.006

Schizophrenia Research
Volume 116, Issue 1 , Pages 27-34, January 2010